Amidine-containing compounds useful as muscarinic receptor antagonists
    31.
    发明授权
    Amidine-containing compounds useful as muscarinic receptor antagonists 有权
    含脒化合物可用作毒蕈碱受体拮抗剂

    公开(公告)号:US08242138B2

    公开(公告)日:2012-08-14

    申请号:US13204302

    申请日:2011-08-05

    CPC classification number: C07D295/195 C07D207/12 C07D211/58 C07D409/12

    Abstract: The invention relates to compounds of formula I: or a pharmaceutically acceptable salt thereof, where R1-3, R5, R7, a, b, Q, X, X′, X″, Y, Z, and Ar are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also relates to pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.

    Abstract translation: 本发明涉及式I化合物或其药学上可接受的盐,其中R1-3,R5,R7,a,b,Q,X,X',X“,Y,Z和Ar如 规范。 这些化合物是毒蕈碱受体拮抗剂。 本发明还涉及含有这种化合物的药物组合物,制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺病的方法。

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
    33.
    发明授权
    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists 有权
    可用作毒蕈碱受体拮抗剂的季铵二苯基甲基化合物

    公开(公告)号:US07834185B2

    公开(公告)日:2010-11-16

    申请号:US12070780

    申请日:2008-02-21

    CPC classification number: C07D207/09 C07D207/08 C07D207/48

    Abstract: The invention provides compounds of formula I: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a-e and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.

    Abstract translation: 本发明提供式I化合物:盐或两性离子形式或其药学上可接受的盐,其中R1-6,a-e和Q如说明书中所定义。 这些化合物是毒蕈碱受体拮抗剂。 本发明还提供含有这些化合物的药物组合物,制备这些化合物的方法和使用这些化合物例如治疗慢性阻塞性肺疾病和哮喘等肺疾病的方法。

    Shoe outsole
    36.
    外观设计

    公开(公告)号:USD512821S1

    公开(公告)日:2005-12-20

    申请号:US29191291

    申请日:2003-10-03

    Applicant: Rick Lee

    Designer: Rick Lee

Patent Agency Ranking